Tuesday, May 19, 2026

4:00 PM - 4:30 PM

---

Details

This session is designed to bring together the investor mindset, founder readiness and scaling realities explored earlier in the program, but through a more applied and interactive lens. Rather than a traditional presentation or panel, the idea is to run this as a scenario-led discussion, where you guide the audience through the types of decisions early-stage life sciences companies are actively facing. Drawing on your experience across company building, commercialisation and growth strategy, the focus would be on unpacking how to think through trade-offs, prioritisation and timing—particularly in today’s more selective capital environment.

---

Speaker